Latest filing published 21 Aug 2026 for Kiniksa Pharmaceuticals International, plc. Read the official filing
Barry D. Quart is a declared insider at 2 companies (chief executive); the most frequent names are Kiniksa Pharmaceuticals International, plc and Heron Therapeutics, Inc. /DE/. Over a trading history stretching from 30 April 2021 to 19 August 2026, the count stands at 20 filings.
The open-market record consists of 2 sales worth €859k, with no purchase. The rest of the record consists of 14 option exercises. 2026 to date brings no purchases and 2 sales.
The newest entry dates from 21 August 2026: a transaction, in Kiniksa Pharmaceuticals International, plc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
20 of 17 declarations